Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| PFO & septal closure · Texas | PFO & septal closure · Florida | |
|---|---|---|
| Surgeons, 2024 | 1 | 0 |
| Medicare fee-for-service cases | 171 | 224 |
| Growth since 2019 (Medicare FFS) | −2.9%/yr | +0.5%/yr |
| Forecast cases (Medicare FFS) | 210 in 2030 | 310 in 2030 |
| Forecast growth | +3.5%/yr to 2030 | +5.8%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.1 | 0.1 |
| Medicare Advantage share | 59% | 60% |
| Out of hospital | 0% (+0 pts since 2024) | 0% (+0 pts since 2019) |
| Cases per surgeon | 171 | – |
| Top 10 surgeons' share | 100% | – |
| Surgeons growing | 0 | 0 |
| New since the base year | 0 | 0 |
| Likely to stop billing it | 1 by 2026 | 0 by 2026 |
| Forecast miss, 1 year (procedure) | 96% | 96% |
| Company payments per surgeon | $127K | – |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.